FeesSafety
Pluang+

FDA grants Breakthrough Therapy status to NervGen's NVG-291 for chronic spinal cord injury treatment

Market News
12 Nov 2026, 14:15 WIB
GlobeNewsWire
View Source
Bullish
FDA grants Breakthrough Therapy status to NervGen's NVG-291 for chronic spinal cord injury treatment

NervGen Pharma's NVG-291 has received FDA Breakthrough Therapy designation for treating chronic traumatic cervical motor-incomplete spinal cord injury (SCI). This designation follows promising Phase 1b/2a clinical data showing improved hand function and independence in patients. NVG-291 aims to promote nerve regeneration, a first in chronic SCI treatment, with ongoing Phase 3 RESTORE study enrolling participants in the US and Canada. The designation may expedite regulatory review, potentially bringing a new therapy to over 300,000 SCI patients in the US.

NervGen's NVG-291 breakthrough therapy designation is contextually framed by Pluang's health sector data. As of Nov 12, 2026 19:11 WIB, 91 of 150 US health stocks rose while 53 fell. Notable movers include Heron Therapeutics Inc (HRTX) at USD 0.35, down 2.59%, with 85% buy order activity, Guardant Health Inc (GH) at USD 158.50, up 2.40%, and Nuwellis Inc (NUWE) at USD 5.66, up 2.35% but with 100% sell orders. Typical hold times range from 10 to 39 days on Pluang.

More News

Tilray's 10 Barrel, Widmer Brothers, and Hop Valley named official craft beer partners of Portland Trail Blazers.

Tilray's 10 Barrel, Widmer Brothers, and Hop Valley named official craft beer partners of Portland Trail Blazers.

Tilray Brands announced that its subsidiaries 10 Barrel Brewing, Widmer Brothers Brewing, and Hop Valley Brewing are now the official craft beer partners of the Portland Trail Blazers. This partnership expands the availability of Oregon craft beers a...

Market News
Bullish
35 minutes ago
Titan Mining's nine-month Adjusted EBITDA jumps 146% to $19.8M, advancing U.S. critical minerals projects.

Titan Mining's nine-month Adjusted EBITDA jumps 146% to $19.8M, advancing U.S. critical minerals projects.

Titan Mining reported a 146% increase in nine-month Adjusted EBITDA to $19.8 million, driven by a 38% rise in revenue to $67.9 million. Despite some production delays, zinc output is expected to improve in Q4 2026. The company is progressing its U.S....

Company Fundamentals
Bullish
1 hour ago
Nexpu completes delivery of 10,000 resale robots worth $4.8M under existing contract

Nexpu completes delivery of 10,000 resale robots worth $4.8M under existing contract

Nexpu Ltd.'s subsidiary, Top Kingwin Hi Tech Inc., has finished delivering all 10,000 TK-D2C robots to Walkers Times International under a $4.8 million resale contract signed in 2025. The deliveries were completed in batches, with the final 5,000 uni...

Market News
Bullish
1 hour ago
Katapult Holdings reports Q3 2026 results with $753.9M revenue, $110.4M adjusted EBITDA, and $30M cost synergies from merger.

Katapult Holdings reports Q3 2026 results with $753.9M revenue, $110.4M adjusted EBITDA, and $30M cost synergies from merger.

Katapult Holdings announced its third quarter 2026 financial results, reporting total revenues of $753.9 million and an adjusted EBITDA of $110.4 million, reflecting a 23% increase year-over-year on a combined basis. The company completed a merger wi...

Company Fundamentals
Neutral
1 hour ago
Three-quarters of U.S. workers plan to freelance within 3 years, valuing independence over salary.

Three-quarters of U.S. workers plan to freelance within 3 years, valuing independence over salary.

A new report from Fiverr reveals that 81% of full-time U.S. employees want to become their own boss, with 42% prioritizing independence over higher pay. This trend, dubbed "The Great Flexit," shows workers quietly preparing to freelance by building A...

Market News
Bullish
1 hour ago
banner-footerbanner-footer

Invest & Trade with
#1 Award-Winning Investment Super App